Coherus BioSciences Inc. (CHRS)
Coherus BioSciences Max Pain By Strike
CHRS trades at $1.04, 4.0% above the near-term max pain of $1 expiring Aug 15, 2025 (-1 days). Price stability likely with balanced options positioning at this level. Max pain is rising across expirations ($0.5-$1), reflecting growing call interest at higher strikes. Key magnetic zone at 1 where 6 expirations converge. High dispersion in max pain levels suggests competing forces and potential volatility.
Coherus BioSciences Max Pain By Expiry
Max pain for CHRS shows an upward trend from 0.5 to 1, suggesting bullish positioning in longer-dated options. The 86% spread signals divergent expectations across timeframes. Most levels below 1.04 may cap rallies. Strong magnetic level at 1 (6 expirations). Weekly expirations influence price 2-3 days before expiry; monthlies throughout their final week.
Max Pain Table
| Expiration Date | Max Pain | Max Pain vs Current Price |
|---|---|---|
| Aug 15, 2025 | 1 | -0.04 (-4.31%) |
| Sep 19, 2025 | 0.5 | -0.54 (-52.15%) |
| Oct 17, 2025 | 0.5 | -0.54 (-52.15%) |
| Nov 21, 2025 | 0.5 | -0.54 (-52.15%) |
| Jan 16, 2026 | 0.5 | -0.54 (-52.15%) |
| Feb 20, 2026 | 0.5 | -0.54 (-52.15%) |